CVS Health names DeVaney
CVS Health names Ed DeVaney president of PBM business
CVS Health names DeVaney as President of CVS Caremark
CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president
· 20h
CVS names new chief executive for Caremark PBM division
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's enough to support a dividend set at just $2.66 per share annually and reduce the company's debt load.
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit moving forward.
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended the role of PBMs in healthcare.
Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, sending shares sharply
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of $97.20 billion,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results